The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 44

More JCP Articles

JCP
Intravenous Scopolamine Versus Active Placebo in MDD
Original Research

August 15, 2022

Scopolamine, an agent commonly used for motion sickness, has shown promise in treating depression. This study measured its efficacy in major depressive disorder versus an active placebo comparator.
, , , et al
JCP
Remission of Psychotic Late-Life Depression Following ECT
Original Research

August 10, 2022

In this study, ECT was associated with a significantly higher remission rate in psychotic versus nonpsychotic late-life depression.
, , , et al
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Insights

August 8, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life…
, , , et al
JCP
Faces Scales to Measure Anxiety and Anger
Original Research

August 8, 2022

Faces scales are used worldwide to assess pain. This study aimed to develop and evaluate measurement properties of faces scales to monitor the mental health symptoms of anxiety and…
, , , et al
JCP
Very Low-Level Transcranial Photobiomodulation for MDD
Original Research

August 8, 2022

Transcranial photobiomodulation may be efficacious for major depressive disorder, but the optimal dose is not known. Here, a very low dose was studied to establish a threshold for lack…
, , , et al
JCP
Cannabidiol for Treatment-Resistant Anxiety
Original Research

August 3, 2022

Treatment resistance affects nearly half of all young patients experiencing moderate-to-severe anxiety. This study investigated the safety and efficacy of cannabidiol for anxiety in young people who previously failed…
, , , et al
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
Academic Highlights

August 3, 2022

Besides achieving symptom relief and improved functioning, many patients with serious mental illness wish to connect more with others and feel engaged with their lives. Five experts discuss life…
, , , et al
JCP
Tardive Dyskinesia and Long-Acting Injectable Antipsychotics
Original Research

August 3, 2022

This study compared spontaneous reporting of tardive dyskinesia with long-acting injectable versus oral antipsychotics.
, ,
JCP
A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole
Letter to the Editor

August 3, 2022

This letter comments on methodological aspects of a recent study by Cohen et al.
, , , et al
JCP
Psychotropic Drugs With Long Half-Lives: Implications for Drug Discontinuation, Dosing, and Pregnancy Planning
Clinical and Practical Psychopharmacology

August 1, 2022

This article gives the essentials of what psychiatrists should know about prescribing drugs with a long half-life.
JCP
Association of Distress Due to Systemic Racism and Racial Disparities With Psychopathology and Suicidal Ideation Among Veterans During COVID-19
Brief Report

August 1, 2022

Data from the National Health and Resilience in Veterans Study shed light on the intersection of systemic racism and the COVID-19 pandemic.
, , , et al
JCP
Timely Diagnosis of Alzheimer Disease
Educational Activity

August 1, 2022

Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in…
,

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe